Mill Capital Management
PFE icon

Mill Capital Management’s Pfizer PFE Stock Holding History

Mill Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.01M Sell
140,638
-3,000
-2% -$79.8K 0.26% 45
2026
Q2 		$3.46M Sell
143,638
-10,227
-7% -$268K 0.23% 47
2026
Q1 		$4.32M Sell
153,865
-4,400
-3% -$117K 0.33% 43
2025
Q4 		$3.94M Hold
158,265
– – 0.28% 43
2025
Q3 		$4.03M Sell
158,265
-12,637
-7% -$312K 0.3% 44
2025
Q2 		$4.14M Sell
170,902
-5,350
-3% -$125K 0.32% 40
2025
Q1 		$4.47M Sell
176,252
-8,653
-5% -$226K 0.36% 39
2024
Q4 		$4.91M Sell
184,905
-5,259
-3% -$143K 0.39% 38
2024
Q3 		$5.5M Sell
190,164
-5,127
-3% -$150K 0.43% 37
2024
Q2 		$5.46M Sell
195,291
-7,679
-4% -$211K 0.45% 38
2024
Q1 		$5.63M Sell
202,970
-2,000
-1% -$55.5K 0.47% 38
2023
Q4 		$5.9M Sell
204,970
-3,576
-2% -$108K 0.53% 38
2023
Q3 		$6.92M Sell
208,546
-953
-0.5% -$33.7K 0.68% 37
2023
Q2 		$7.68M Buy
209,499
+7,277
+4% +$283K 0.72% 37
2023
Q1 		$8.25M Sell
202,222
-8,915
-4% -$385K 0.84% 34
2022
Q4 		$10.8M Hold
211,137
– – 1.19% 30
2022
Q3 		$9.24M Sell
211,137
-303
-0.1% -$14.7K 1.08% 27
2022
Q2 		$11.1M Hold
211,440
– – 1.23% 27
2022
Q1 		$10.9M Sell
211,440
-2,340
-1% -$121K 1.05% 32
2021
Q4 		$12.6M Buy
+213,780
New +$10.6M 1.29% 23

Other funds holding PFE

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Mill Capital Management's PFE Position: Q3 2026 in Review

Mill Capital Management reduced its Pfizer (PFE) stake by 2.1% in Q3 2026, selling an estimated $79.8K and leaving 140,638 shares worth $4.01M. The position accounts for 0.26% of the portfolio, ranked #45.

Mill Capital Management first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. The position peaked at $12.6M in Q4 2021. 1,327 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Mill Capital Management held 140,638 shares of Pfizer worth $4.01M as of Q3 2026.
  • Mill Capital Management sold 3,000 Pfizer shares in Q3 2026, an estimated $79.8K.
  • Pfizer made up 0.26% of Mill Capital Management's portfolio in Q3 2026, its #45 holding.
  • Mill Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
  • Mill Capital Management's Pfizer position peaked at $12.6M in Q4 2021.
  • 1,327 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Mill Capital Management's 13F filing for Q3 2026, filed 26 Oct 2026.